Stephen Burgess, Ph.D., serves as Managing Director of Avanti Polar Lipids, and he is Head of Lipid Technology and Nucleic Acid Delivery for Croda Pharma, supporting the group’s vision to become the global leader in empowering biologics delivery. Over the past 30 years, he has worked with numerous researchers to develop novel lipids and lipid formulations to address specific experimental challenges and improve drug delivery. He has played a key role in a diverse list of projects, including drug delivery development, gene therapy, wound healing, and vaccine development. His background in lipid synthesis, lipid biophysical properties, and membrane dynamics has been instrumental in resolving problems associated with these projects.